Literature DB >> 2974921

Concentration dependence of transcriptional transactivation in inducible E1A-containing human cells.

L J Brunet1, A J Berk.   

Abstract

The adenovirus E1A proteins are essential for the normal temporal activation of transcription from every other adenoviral early promoter. High-level E1A expression in the absence of viral infection would facilitate biochemical studies of E1A-mediated transactivation. Toward this end, we introduced the adenovirus type 2 E1A gene under the control of the murine mammary tumor virus promoter into HeLa cells. Uninduced cells expressed little or no detectable E1A mRNA. Upon induction, mRNA levels accumulated to about 50% of the level observed in 293 cells. The level of E1A expression in these cells could be controlled by varying the concentration of the inducing glucocorticoid. Under these conditions of varying E1A concentrations, it was observed that activation of the E2, E3, and E4 promoters of H5dl312 initiated at the same E1A concentration and that transcription from each promoter increased as the E1A concentration increased. These results indicate that E1A-mediated transactivation is proportional to the concentration of E1A protein. E1A-dependent transcriptional stimulation of the E4 promoter was reproduced in an in vitro transcription system, demonstrating that expression of only the E1A proteins was sufficient to increase the transcriptional activity of nuclear extracts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974921      PMCID: PMC365573          DOI: 10.1128/mcb.8.11.4799-4807.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

3.  Plasmid cloning vehicles derived from plasmids ColE1, F, R6K, and RK2.

Authors:  M Kahn; R Kolter; C Thomas; D Figurski; R Meyer; E Remaut; D R Helinski
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

5.  Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome.

Authors:  R Wittek; M Hänggi; G Hiller
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

6.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

7.  Complete transformation by adenovirus 2 requires both E1A proteins.

Authors:  C Montell; G Courtois; C Eng; A Berk
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis.

Authors:  L E Babiss; H S Ginsberg
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

10.  Mapping a eukaryotic promoter: a DNA sequence required for in vivo expression of adenovirus pre-early functions.

Authors:  T F Osborne; R E Schell; E Burch-Jaffe; S J Berget; A J Berk
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  16 in total

1.  The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines.

Authors:  M I Cockett; C R Bebbington; G T Yarranton
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Adenovirus E1A protein activates transcription of the E1A gene subsequent to transcription complex formation.

Authors:  J Schaack; J Logan; E Vakalopoulou; T Shenk
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 3.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

4.  E1a transactivation of human HSP70 gene promoter substitution mutants is independent of the composition of upstream and TATA elements.

Authors:  I C Taylor; R E Kingston
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

5.  E1a transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex.

Authors:  G T Williams; T K McClanahan; R I Morimoto
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site.

Authors:  G F Morris; M B Mathews
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor.

Authors:  L S Chang; Y Shi; T Shenk
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator.

Authors:  D M Becker; S M Hollenberg; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression.

Authors:  J M Routes; B A Metz; J L Cook
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Analysis of the specificity and mechanism of transcriptional activation of the human hsp70 gene during infection by DNA viruses.

Authors:  B Phillips; K Abravaya; R I Morimoto
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.